Company Overview
CELLDEX THERAPEUTICS, INC.
CLDXRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
2M
2025 FY
Net Income
-259M
2025 FY
Shares Outstanding
66M
2025 FY
EPS
-3.9USD
2025 FY
Company Information
SIC Code
2835
CIK Code
744218
Exchange
Nasdaq
Location
US